Beyond the Prescription: Addressing the Root Cause of Illness

garzaj25
Apr 26
3 min read

Modern medicine has delivered extraordinary advances in the treatment of disease. From antibiotics to psychotropics, prescription drugs have saved and continue to save millions of lives.

But as prescribing rates rise, an uncomfortable question persists: Are we treating symptoms while overlooking underlying causes?

The Symptom–Solution Gap

In many cases, medications are prescribed to manage outward symptoms, anxiety, depression, inflammation, and hypertension without fully addressing the biological terrain beneath them.

Emerging research across neuroscience and behavioral health suggests that many conditions may be influenced or even driven by:

Neurological dysfunction and neuroinflammation
Nutritional deficiencies (e.g., B vitamins, vitamin D, omega-3s)
Hormonal and metabolic imbalances
Gut-brain axis disruption
Environmental and lifestyle stressors

For example, nutrient deficiencies and chronic inflammation have been linked to mood disorders and cognitive decline. Yet instead of correcting these drivers, the default intervention often becomes pharmacological.

This is not inherently wrong but it is often incomplete.

The Expanding Role of Prescription Drugs

Prescription medications are frequently positioned as first-line solutions, particularly in behavioral health. While effective in stabilizing symptoms, this approach can reinforce a “pill for every ill” mindset reducing complex, multifactorial conditions to isolated chemical imbalances.

The Reality of Adverse Drug Events

According to medication safety data from the Center for Disease Control and Prevention, medications carry risk alongside benefit. Adverse Drug Events (ADEs) remain a significant public health concern:

Over 1.5 million emergency department visits annually in the U.S. are linked to ADEs
Nearly 500,000 hospitalizations each year result from medication-related harm
Approximately 1.5 million preventable ADEs occur annually
440,000 U.S. deaths occur per year from preventable medical error (1,000 people per day)

High-risk categories include anticoagulants, opioids, antibiotics, diabetes medications, antidepressants and antipsychotics. Older adults often managing multiple prescriptions face the greatest vulnerability.

In some cases, treatment itself becomes part of the problem, creating cycles of polypharmacy where new symptoms lead to additional medications rather than deeper evaluation.

Bridging the Gap: Biology, Data, and Precision Medicine

Encouragingly, a shift is underway. The Million Veteran Program (MVP) represents one of the most ambitious efforts to move beyond symptom-based care.

This national research program is building one of the largest health databases in the world by integrating:

Genomic (genetic) data
Electronic health records (EHRs)
Lifestyle and behavioral information
Environmental and military exposure data

By linking these domains, MVP allows researchers to study how genes, lifestyle, and environment interact to influence health and disease.

At the state level, complementary efforts are also advancing this shift toward proactive, data-informed care. The State of Ohio Adversity and Resilience Study (SOAR) is a first-of-its-kind mental health research effort, bringing together government, academia, and the private sector. By examining how adversity, resilience, and environmental factors shape mental health outcomes, SOAR contributes to a more comprehensive understanding of population health, aligning with the same holistic, multi-factor approach exemplified by MVP.

These integrated models are critical. They recognize that:

Genetic predispositions may influence how individuals respond to medications
Lifestyle factors can either mitigate or exacerbate biological risk
Behavioral health conditions often have physiological and neurological underpinnings

Together, these efforts represent a rapidly expanding body of research. With more than one million participants in MVP alongside growing participation in SOAR, these initiatives are collectively advancing precision medicine by tailoring prevention and treatment strategies based on the full complexity of the individual, not just symptoms.

When Treatment Becomes Insight

Programs like MVP and SOAR highlight a fundamental shift: Instead of asking “What drug treats this symptom?” We begin asking“What system is driving this condition?”

This shift has profound implications:

Identifying biomarkers for mental health conditions
Understanding medication response variability (pharmacogenomics)
Detecting early disease risk before symptoms emerge
Designing interventions that combine medical, nutritional, and behavioral strategies

A More Complete Model of Care

The future of healthcare especially behavioral health will depend on integration:

Medicine (pharmacogenomics)
Neuroscience
Nutrition
Genomics
Behavioral science

Medication will remain a powerful tool. But it should be informed by deeper biological insight, not used as a substitute for it.

Moving Forward

A pill may relieve symptoms. But it does not always resolve the cause. The next era of care is not about abandoning medication it’s about using it within a system that understands the whole person. Because lasting outcomes require more than symptom management. They require understanding the biology, behavior, and environment that created the condition in the first.